Back to results
US 2020/0402633 A1Published application
Dynamic equivalent on board estimator
AssigneeDexCom, Inc.
InventorsStephen D. Patek, Enrique Campos-Náñez
Life of this patent
Estimating the term…
Abstract
Adaptive on board estimation of exogenous pharmacon responsive to transient (i.e., impermanent) physiological effects is provided. Dynamically estimating an equivalent amount of an exogenous pharmacon on board (XOB), such as insulin and/or carbohydrates, left in the subject, is based on predictions of glucose time-series data. These estimated values, such as insulin on board (IOB), are useful for diabetes management software, including decision support and/or artificial pancreas (AP) algorithms, for example.
Claims29
A system comprising:
- an input compiler configured to receive and process input data;
- an exogenous pharmacon on board (XOB) estimator;
- and
- an output compiler.
1 more element
A system comprising:
- an input compiler, wherein the input compiler receives and processes input data relating to a pharmacon;
- an exogenous pharmacon on board (XOB) estimator, wherein the XOB estimator uses estimation to account for transient changes in pharmacon absorption of the pharmacon, and wherein the XOB estimator determines an XOB estimation;
- and
- an output compiler, wherein the output compiler renders the XOB estimation.
1 more element
A system comprising:
- a monitoring device configured to receive input data pertaining to a patient;
- a handheld computing device configured to receive the input data from the monitoring device;
- and
- an exogenous pharmacon on board (XOB) calculator configured to perform an XOB estimation using the input data.
1 more element
Dependencies are inferred from the claim text.